|
Company
Roster
|
Total
Insiders : |
45 |
|
|
Total
Direct Shares :
|
10,664,675 |
|
Total
Indirect Shares :
|
15,769,226 |
|
%
Held by Insiders:
|
10.56% |
|
|
|
Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Osborne Aaron |
|
|
0 |
|
0 |
Versant Capital Iv (switzerland) Gmbh |
10% Owner |
|
0 |
2016-05-11 |
7,003,892 |
Russo Carlo |
|
|
0 |
|
0 |
Vhcp Management Ii, Llc |
10% Owner |
2014-08-05 |
0 |
2014-08-05 |
2,365,471 |
Deerfield International Master Fund, L.p. |
Possible Members of 10% Group, 10% Owner |
2014-08-05 |
0 |
2014-08-05 |
627,267 |
Regeneron Pharmaceuticals Inc |
10% Owner |
2014-08-05 |
1,809,098 |
2014-08-05 |
0 |
Koh Bong Y |
10% Owner |
2014-08-05 |
0 |
2014-08-05 |
2,365,471 |
Zygtech, Llc |
10% Owner |
2015-04-14 |
2,438,176 |
2014-08-05 |
0 |
Guerin John Patrick Et Al |
Director, 10% Owner |
2015-05-27 |
0 |
2015-06-10 |
200,000 |
Chalberg Thomas W. |
Chief Executive Officer, Director |
2015-06-10 |
258,988 |
2015-06-10 |
840,413 |
Bain Linda |
Chief Financial Officer |
2015-08-21 |
41,930 |
2015-04-21 |
0 |
Hull Hans |
Chief Executive Officer |
2015-08-21 |
137,210 |
2014-08-05 |
0 |
Blumenkranz Mark S. |
Director |
2016-02-12 |
531,322 |
2016-02-12 |
31,593 |
Braun Shirley |
VP, Human Resources |
2016-02-12 |
161,140 |
2015-09-21 |
0 |
Mclaughlin John Peter |
Director |
2016-02-12 |
10,333 |
2016-02-12 |
26,560 |
Rubio Roman G. |
SVP, Translational Medicine |
2016-02-12 |
165,650 |
2015-04-21 |
0 |
Swartzburg Michael |
Principal Accounting Officer |
2016-02-12 |
82,113 |
2016-02-12 |
0 |
Wachter Paul |
Director |
2016-02-29 |
31,951 |
2016-02-29 |
37,161 |
Salzman Amber |
President and CEO, Director |
2017-02-09 |
891,766 |
2016-05-11 |
0 |
Barone Samuel B. |
SVP, Clinical Development |
2017-02-09 |
172,335 |
2015-04-21 |
0 |
Finer Mitchell H. |
Director |
2017-06-12 |
603,069 |
|
0 |
Schwartz Steven Daniel |
Director |
2017-06-12 |
398,991 |
2014-08-05 |
0 |
Cleveland Paul B |
Chief Executive Officer, Director |
2017-06-12 |
22,727 |
2017-06-12 |
0 |
Spivey Richard N. |
Director |
2017-06-12 |
70,804 |
2017-04-19 |
0 |
Countouriotis Athena |
SVP, Chief Medical Officer |
2017-06-19 |
150,000 |
2017-06-19 |
0 |
Carter Eric G |
Director |
2017-09-07 |
48,000 |
2017-09-07 |
0 |
Cheng Jennifer C. |
General Counsel |
2018-06-15 |
118,863 |
2018-06-15 |
0 |
Gasmi Mehdi |
Director |
2020-07-20 |
274,442 |
2015-04-07 |
0 |
Woiwode Thomas |
Director |
2020-12-14 |
18,822 |
2016-05-11 |
0 |
Patterson Leone D |
President and CFO |
2021-02-09 |
97,955 |
2016-06-15 |
0 |
Machado Clarence Patrick |
Director |
2021-03-24 |
88,182 |
2017-03-14 |
0 |
Thedinga Angela |
Chief Technology Officer |
2021-08-06 |
150,000 |
2021-08-06 |
0 |
Clark Julie |
Chief Medical Officer |
2021-09-30 |
164,723 |
|
0 |
Graham Dawn |
Director |
2022-05-16 |
50,000 |
2021-03-31 |
0 |
Dsouza Rupert |
Chief Financial Officer |
2022-05-17 |
20,850 |
|
0 |
Rakow John |
Officer |
2022-06-03 |
58,233 |
|
0 |
Beckman Richard |
Chief Medical Officer |
2022-09-19 |
39,061 |
2022-05-17 |
0 |
Riley Brigit |
Chief Scientific Officer |
2023-03-15 |
117,435 |
|
0 |
Fischer Laurent |
CEO, President and Director, Director |
2023-03-15 |
692,141 |
2020-08-17 |
0 |
Soparkar Peter |
Chief Operating Officer |
2023-03-15 |
265,891 |
2020-08-17 |
0 |
Rubinstein Linda M |
Chief Financial Officer |
2023-06-07 |
100,000 |
2023-06-07 |
0 |
Seyedkazemi Setareh |
Chief Development Officer |
2023-09-15 |
47,674 |
|
0 |
Lupher, Jr. Mark L. |
|
2024-02-07 |
130,000 |
2024-02-07 |
0 |
Scopa James Paul |
|
2024-02-07 |
100,000 |
2024-02-07 |
3,334 |
Leonard Braden Michael |
|
2024-07-30 |
104,800 |
2024-07-30 |
2,268,064 |
|
|